Safety and efficacy of allogeneic stem cell transplantation after nivolumab therapy for patients with relapsed/refractory classical Hodgkin lymphoma

被引：0
|
作者：
Beynarovich, A. [1 ]
Lepik, K. [2 ]
Mikhailova, N. [3 ]
Kondakova, E. [2 ]
Zalyalov, Y. [2 ]
Moiseev, I. [2 ]
Afanasyev, B. [2 ]
机构：
[1] Pavlov First St Petersburg State Med Univ, Raisa Gorbacheva Mem Res Inst Children Oncol Hema, St Petersburg, Russia
[2] Raisa Gorbacheva Mem Res Inst Children Oncol Hema, Hematol, St Petersburg, Russia
[3] Sci Res Inst Pediat Oncol Hematol & Transplantol, Raisa Gorbacheva Mem Res Inst Children Oncol Hema, St Petersburg, Russia
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
62P
引用
收藏
页码：22 / +
页数：2
相关论文
共 50 条
  • [1] Nivolumab salvage therapy before and after allogeneic stem cell transplantation in relapsed/refractory hodgkin lymphoma
    Cheikh, J. E. I.
    Massoud, R.
    Abudalle, I.
    Haffar, B.
    Mahfouz, R.
    Kharfan-Dabaja, M. A.
    Jisr, T.
    Mougharbel, A.
    Ibrahim, A.
    Bazarbachi, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S29 - S30
  • [2] Safety and Efficacy of Allogeneic Stem Cell Transplantation after PD-1 Blockade for Patients with Relapsed/Refractory Classical Hodgkin Lymphoma
    Beynarovich, Anastasiya V.
    Lepik, Kirill
    Mikhailova, Nataliia
    Kondakova, Elena
    Zalaylov, Yuri
    Borzenkova, Evgeniya
    Babenko, Elena
    Darskaya, Elena I.
    Moiseev, Ivan S.
    Zander, Axel
    Afanasyev, Boris
    BLOOD, 2019, 134
  • [3] Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation
    J A Yared
    N Hardy
    Z Singh
    S Hajj
    A Z Badros
    M Kocoglu
    S Yanovich
    E A Sausville
    C Ujjani
    K Ruehle
    C Goecke
    M Landau
    A P Rapoport
    Bone Marrow Transplantation, 2016, 51 : 850 - 852
  • [4] Efficacy of Haploidentical Stem Cell Transplantation for Patients with Relapsed/refractory Classical Hodgkin Lymphoma
    Beynarovich, Anastasiya
    Lepik, Kirill
    Mikhailova, Natalia
    Kondakova, Elena
    Zalyalov, Yurii
    Borzenkova, Eugenia
    Babenko, Elena
    Darskaya, Elena
    Aliynskiy, Alexander
    Moiseev, Ivan
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 519 - 520
  • [5] Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation
    Yared, J. A.
    Hardy, N.
    Singh, Z.
    Hajj, S.
    Badros, A. Z.
    Kocoglu, M.
    Yanovich, S.
    Sausville, E. A.
    Ujjani, C.
    Ruehle, K.
    Goecke, C.
    Landau, M.
    Rapoport, A. P.
    BONE MARROW TRANSPLANTATION, 2016, 51 (06) : 850 - 852
  • [6] Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) after Treatment with Nivolumab for Relapsed/Refractory Hodgkin Lymphoma
    Armand, Philippe
    Zinzani, Pier Luigi
    Collins, Graham P.
    Cohen, Jonathon B.
    Halwani, Ahmad S.
    Carlo-Stella, Carmelo
    Millenson, Michael M.
    Provencio, Mariano
    Domenech, Eva Domingo
    Roth, Lisa Giulino
    Castagna, Luca
    Kato, Kazunobu
    McKiver, Mihaela Popa
    Sumbul, Anne
    Zhu, Lili
    Santoro, Armando
    BLOOD, 2016, 128 (22)
  • [7] Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma
    Herbaux, Charles
    Gauthier, Jordan
    Brice, Pauline
    Drumez, Elodie
    Ysebaert, Loic
    Doyen, Helene
    Fornecker, Luc
    Bouabdallah, Krimo
    Manson, Guillaume
    Ghesquieres, Herve
    Tabrizi, Reza
    Hermet, Eric
    Lazarovici, Julien
    Thiebaut-Bertrand, Anne
    Chauchet, Adrien
    Demarquette, Helene
    Boyle, Eileen
    Houot, Roch
    Yakoub-Agha, Ibrahim
    Morschhauser, Franck
    BLOOD, 2017, 129 (18) : 2471 - 2478
  • [8] Nivolumab in a patient with refractory Hodgkin's lymphoma after allogeneic stem cell transplantation
    Angenendt, L.
    Schliemann, C.
    Lutz, M.
    Rebber, E.
    Schulze, A. B.
    Weckesser, M.
    Stegger, L.
    Schaefers, M.
    Groth, C.
    Kessler, T.
    Lenz, G.
    Stelljes, M.
    Berdel, W. E.
    BONE MARROW TRANSPLANTATION, 2016, 51 (03) : 443 - 445
  • [9] Nivolumab in a patient with refractory Hodgkin’s lymphoma after allogeneic stem cell transplantation
    L Angenendt
    C Schliemann
    M Lutz
    E Rebber
    A B Schulze
    M Weckesser
    L Stegger
    M Schäfers
    C Groth
    T Kessler
    G Lenz
    M Stelljes
    W E Berdel
    Bone Marrow Transplantation, 2016, 51 : 443 - 445
  • [10] Allogeneic stem cell transplantation in refractory Hodgkin's lymphoma after CR with Nivolumab
    Fellas, G.
    Kiehl, M.
    Hopfer, O.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 74 - 74
12345